A novel method in myocardial injury risk stratification using intravenous fat emulsion as sole rapid preparation for unfasted patients to suppress myocardial 18F-fluorodeoxyglucose uptake for optimal cardiac PET imaging: a proof-of-concept randomized
Intravenous lipid emulsion suppresses background metabolic uptake of <sup>18</sup>F-FDG even in unprepared and unfasted patients. Our findings prove and expand the possible applications for cardiac <sup>18</sup>F-FDG PET in various settings, including in emergent settings as a means of rapid preparation in place of current more time-consuming standard protocols, allowing time-critical management to be effected.
Authors
- Christopher C. Rowe (ORCID: https://orcid.org/0000-0003-3910-2453)
- Michael H-G. Li
- Raef R. Boktor (ORCID: https://orcid.org/0000-0003-4861-619X)
- Bernhard Riedel (ORCID: https://orcid.org/0000-0003-2577-3918)
- Laurence Weinberg (ORCID: https://orcid.org/0000-0001-7403-7680)
Institutions
- The University of Melbourne (AU)
- La Trobe University (AU)
- Peter MacCallum Cancer Centre (AU)
- Olivia Newton-John Cancer Wellness & Research Centre (AU)
- Austin Health (AU)
Publication Details
- Journal
- Frontiers in Nuclear Medicine
- Published
- 2024-10-23
- DOI
- https://doi.org/10.3389/fnume.2024.1412917
- Citations
- 1
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.40